|
Volumn 23, Issue 5, 2013, Pages 1347-1350
|
Discovery of olmesartan hexetil: A new potential prodrug of olmesartan
|
Author keywords
Antihypertensive; Ester; Olmesartan hexetil; Olmesartan medoxomil; Pharmacokinetics; Prodrug
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
CANDESARTAN;
OLMESARTAN;
OLMESARTAN HEXETIL;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD SAMPLING;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG DESIGN;
DRUG HALF LIFE;
DRUG HYDROLYSIS;
DRUG METABOLISM;
DRUG STABILITY;
DRUG SYNTHESIS;
IN VITRO STUDY;
IN VIVO STUDY;
LIVER MICROSOME;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
PHARMACOLOGICAL PARAMETERS;
RAT;
STOMACH JUICE;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
BIOLOGICAL AVAILABILITY;
DRUG DISCOVERY;
DRUG STABILITY;
ESTERS;
GASTRIC JUICE;
IMIDAZOLES;
MALE;
MICROSOMES, LIVER;
PRODRUGS;
RATS;
RATS, SPRAGUE-DAWLEY;
TETRAZOLES;
RATTUS;
|
EID: 84873714069
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.12.090 Document Type: Article |
Times cited : (4)
|
References (19)
|